Eli Lilly and Company - Product Pipeline Review – 2016 Market Research Report
Eli Lilly and Company - Product Pipeline Review - 2016 Size and Share Published in 2016-02-29 Available for US$ 1500 at Researchmoz.us
Description
Global Markets Directs, Eli Lilly and Company - Product Pipeline Review - 2016, provides an overview of the Eli Lilly and Companys pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Eli Lilly and Company, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Download Sample of this Report at: http://www.researchmoz.us/enquiry.php?type=S&repid=685387
Scope
- The report provides a snapshot of the pipeline therapeutic landscape of Eli Lilly and Company
- The report provides overview of Eli Lilly and Company including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Eli Lilly and Companys pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Eli Lilly and Companys out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
- Evaluate Eli Lilly and Companys strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Eli Lilly and Company
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Eli Lilly and Companys pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Make an Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=685387
Table of Content
Table of Contents 2
List of Tables 6
List of Figures 6
Eli Lilly and Company Snapshot 7
Eli Lilly and Company Overview 7
Key Information 7
Key Facts 7
Eli Lilly and Company - Research and Development Overview 8
Key Therapeutic Areas 8
Eli Lilly and Company - Pipeline Review 17
Pipeline Products by Stage of Development 17
Pipeline Products - Monotherapy 18
Pipeline Products - Combination Treatment Modalities 19
Pipeline Products - Partnered Products 20
Pipeline Products - Out-Licensed Products 22
Eli Lilly and Company - Pipeline Products Glance 24
Eli Lilly and Company - Late Stage Pipeline Products 24
Eli Lilly and Company - Clinical Stage Pipeline Products 27
Eli Lilly and Company - Early Stage Pipeline Products 31
Browse All Pharmaceutical Market Research Reports at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.
Contact Us:
ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/
For More Report Click Here @ http://www.prweb.com/search.aspx?search-releases=researchmoz&hitsPerPage=20